Search Results - "Grembiale, R D"

Refine Results
  1. 1

    Kaposi's sarcoma after T‐cell costimulation blockade with abatacept in rheumatoid arthritis: a case report by Olivo, D., Grembiale, R. D., Tallarigo, F., Russo, E., De Sarro, G., Ursini, F.

    “…Summary What is known and objective Kaposi's sarcoma (KS) is a malignant neoplasm caused by HHV‐8, a pathogen that leads to endothelial cell transformation…”
    Get full text
    Journal Article
  2. 2

    Efficacy and safety of duloxetine in fibromyalgia by Ursini, F, Pipicelli, G, Grembiale, R D

    Published in Clinica terapeutica (01-07-2010)
    “…Fibromyalgia is a chronic disorder of uncertain aetiology, more common in women than in man, characterized by widespread pain, muscle tenderness and decreased…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Omalizumab decreases exacerbation frequency, oral intake of corticosteroids and peripheral blood eosinophils in atopic patients with uncontrolled asthma by Pelaia, G, Gallelli, L, Romeo, P, Renda, T, Busceti, M T, Proietto, A, Grembiale, R D, Marsico, S A, Maselli, R, Vatrella, A

    “…Omalizumab is a humanized monoclonal anti-IgE antibody approved in 2005 by the European Medicine Agency (EMA) for the treatment of severe persistent allergic…”
    Get full text
    Journal Article
  5. 5

    Endothelial dysfunction and non-alcoholic liver steatosis in hypertensive patients by Sciacqua, A, Perticone, M, Miceli, S, Laino, I, Tassone, E.J, Grembiale, R.D, Andreozzi, F, Sesti, G, Perticone, F

    “…Abstract Background and aims Non-alcoholic fatty liver disease, characterized by insulin resistance, has been correlated with several clinical and pathological…”
    Get full text
    Journal Article
  6. 6

    Potential role of potassium channel openers in the treatment of asthma and chronic obstructive pulmonary disease by Pelaia, G., Gallelli, L., Vatrella, A., Grembiale, R.D., Maselli, R., De Sarro, G.B., Marsico, S.A.

    Published in Life sciences (1973) (18-01-2002)
    “…Airway smooth muscle (ASM) cells express various types of potassium (K +) channels which play a key role in determining the resting membrane potential, a…”
    Get full text
    Journal Article
  7. 7

    Sudden progression from impaired glucose tolerance to type 2 diabetes after discontinuation of administration of anti-tumor necrosis factor-alpha antibody infliximab by Ursini, F, Succurro, E, Grembiale, A, Rudi, S, Grembiale, R D, Arturi, F

    “…We present the case of a 45-year-old man with psoriasis and psoriatic arthritis and concomitant impaired fasting glucose (IFG) and impaired glucose tolerance…”
    Get more information
    Journal Article
  8. 8

    Short-term cardiovascular effects of salmeterol by Tranfa, C M, Pelaia, G, Grembiale, R D, Naty, S, Durante, S, Borrello, G

    Published in Chest (01-05-1998)
    “…The occurrence of cardiovascular side effects is sometimes associated with the utilization of beta-adrenoceptor agonists. The most important causes of these…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Effects of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsiveness by GREMBIALE, Rosa D, CAMPOROTA, Luigi, NATY, Saverio, TRANFA, Carmelindo M. E, DJUKANOVIC, Ratko, MARSICO, Serafino A

    “…Allergic rhinitis can be associated with bronchial hyperresponsiveness (BHR), and carries an increased risk for the development of asthma. The aim of this…”
    Get full text
    Conference Proceeding Journal Article
  11. 11

    Chronic obstructive pulmonary disease (COPD) treatment in the elderly by Grembiale, RD, Naty, S, Ursini, F

    Published in BMC geriatrics (27-08-2010)
    “…Scientific evidences demonstrated that COPD is a systemic disease, characterized by a high prevalence of co-morbid conditions such as cardiovascular disease,…”
    Get full text
    Journal Article
  12. 12

    Oxidative stress and lung diseases by Maselli, R, Grembiale, R D, Pelaia, G, Cuda, G

    Published in Monaldi archives for chest disease (01-06-2002)
    “…Several different lung diseases are characterized by an oxidant/antioxidant imbalance, which is a major cause of cell damage. Oxidative stress activates a…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Serum complement C3 strongly correlates with whole-body insulin sensitivity in rheumatoid arthritis by Ursini, Francesco, D'Angelo, Salvatore, Russo, Emilio, Arturi, Franco, D'Antona, Lucia, Bruno, Caterina, Naty, Saverio, De Sarro, Giovambattista, Olivieri, Ignazio, Grembiale, Rosa Daniela

    Published in Clinical and experimental rheumatology (01-01-2017)
    “…Rheumatoid arthritis (RA) is characterised by an excess of cardiovascular diseases (CVD) risk, attributable to a synergy between under-diagnosed traditional…”
    Get full text
    Journal Article
  15. 15

    Lipid Oxidation Assessed by Indirect Calorimetry Predicts Metabolic Syndrome and Type 2 Diabetes by Pujia, Arturo, Mazza, Elisa, Ferro, Yvelise, Gazzaruso, Carmine, Coppola, Adriana, Doldo, Patrizia, Grembiale, Rosa Daniela, Pujia, Roberta, Romeo, Stefano, Montalcini, Tiziana

    Published in Frontiers in endocrinology (Lausanne) (10-01-2019)
    “…Diabetes has been linked to an impaired ability to oxidize fatty acids. Fat oxidation can be assessed clinically by a respiratory quotient measurement during…”
    Get full text
    Journal Article
  16. 16

    Bronchial asthma induced by an antithyroid drug by Grembiale, R D, Naty, S, Iorio, C, Crispino, N, Pelaia, G, Tranfa, C M

    Published in Chest (01-05-2001)
    “…We report the case of a 67-year-old woman who suffered from a severe asthma exacerbation as a consequence of an antithyroid drug treatment prescribed for her…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Update on optimal use of omalizumab in management of asthma by Pelaia, Girolamo, Gallelli, Luca, Renda, Teresa, Romeo, Pasquale, Busceti, Maria Teresa, Grembiale, Rosa Daniela, Maselli, Rosario, Marsico, Serafino Antonio, Vatrella, Alessandro

    Published in Journal of asthma and allergy (01-01-2011)
    “…Omalizumab is a humanized monoclonal anti-IgE antibody recently approved for the treatment of severe allergic asthma. This drug inhibits allergic responses by…”
    Get full text
    Journal Article
  19. 19
  20. 20